Headlands Technologies LLC Has $4.67 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Headlands Technologies LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 28.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,754 shares of the medical device company's stock after acquiring an additional 11,099 shares during the quarter. Headlands Technologies LLC's holdings in Cooper Companies were worth $4,666,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in COO. Fulton Bank N.A. increased its holdings in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after purchasing an additional 109 shares during the last quarter. Torray Investment Partners LLC grew its stake in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after buying an additional 132 shares during the last quarter. Mather Group LLC. raised its holdings in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after acquiring an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after acquiring an additional 136 shares during the last quarter. Finally, Greenleaf Trust boosted its holdings in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock worth $268,000 after acquiring an additional 139 shares during the period. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of COO stock traded down $4.40 on Friday, hitting $73.77. 2,661,526 shares of the company's stock were exchanged, compared to its average volume of 1,367,710. The company has a 50 day moving average of $87.76 and a 200 day moving average of $96.24. The stock has a market cap of $14.75 billion, a P/E ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 12 month low of $73.34 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on COO shares. Wells Fargo & Company increased their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup reduced their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, BNP Paribas raised Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.